These statements may relate to, among other things, (i) our future plans and results, including our target ROE, ROTE, efficiency ratio and CET1 capital ratio, and how they can be achieved,
(ii) legal proceedings, governmental investigations or other contingencies as set forth in Notes 27 and 18 to the consolidated financial statements in Part I, Item 1 of this
Form 10-Q,
(iii) the results of stress tests, (iv) the objectives and effectiveness of our BCP strategy, information security program, risk management and liquidity policies, (v) our resolution plan and resolution strategy and their implications for stakeholders, (vi) the design and effectiveness of our resolution capital and liquidity models and triggers and alerts framework, (vii) trends in or growth opportunities for our businesses, including the timing, profitability, benefits and other aspects of business and strategic initiatives and changes in and the importance of our efficiency ratio, (viii) the effect of changes to regulations, and our future status, activities or reporting under banking and financial regulation, (ix) our NSFR, (x) our level of future compensation expense as a percentage of operating expenses, (xi) our investment banking transaction backlog, (xii) our expected tax rate, (xiii) the future state of our liquidity and regulatory capital ratios, and our prospective capital distributions (including dividends), (xiv) our expected interest income, (xv) our credit exposures, (xvi) our expected provisions for credit losses, (xvii) our preparations for Brexit, (xviii) the replacement of LIBOR and other IBORs and our program for the transition to alternative risk-free reference rates, (xix) the adequacy of our allowance for credit losses, (xx) the projected growth of our deposits and related interest expense savings, (xxi) the projected growth of our installment loan and credit card businesses, (xxii) our business initiatives, including
transaction banking
and new consumer financial products, (xxiii) our expense savings and strategic locations initiatives, (xxiv) our planned 2020 parent vanilla debt issuances, (xxv) the amount of GCLA we expect to hold, (xxvi) our expected SCB and
G-SIB
surcharge,
(xxvii) the impact of the
COVID-19
pandemic on our business, results, financial position and liquidity, (xxviii) the settlements relating to 1MDB, including the asset recovery guarantee and our remediation activities and (xxix) expenses we may incur, including future litigation expense and expenses from investing in our installment loan, credit card and transaction banking businesses.